343
Views
10
CrossRef citations to date
0
Altmetric
Reviews

The preclinical discovery of amyotrophic lateral sclerosis drugs

Pages 1127-1138 | Published online: 25 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt & Péter Mátyus. (2012) Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 21:9, pages 1267-1308.
Read now

Articles from other publishers (9)

Alyssa Walker & Daniel M. Czyz. (2023) Oh my gut! Is the microbial origin of neurodegenerative diseases real?. Infection and Immunity 91:10.
Crossref
Roohi Mohi-ud-din, Reyaz Hassan Mir, Abdul Jalil Shah, Saba Sabreen, Taha Umair Wani, Mubashir Hussain Masoodi, Esra Küpeli Akkol, Zulfiqar Ali Bhat & Haroon Khan. (2022) Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update. Current Neuropharmacology 20:1, pages 179-193.
Crossref
Benjamin C Creekmore, Yi-Wei Chang & Edward B Lee. (2021) The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates. Journal of Neuropathology & Experimental Neurology 80:6, pages 514-529.
Crossref
Žiga Jakopin. (2020) 2-aminothiazoles in drug discovery: Privileged structures or toxicophores?. Chemico-Biological Interactions 330, pages 109244.
Crossref
Shunmoogum A. Patten, Dina Aggad, Jose Martinez, Elsa Tremblay, Janet Petrillo, Gary A.B. Armstrong, Alexandre La Fontaine, Claudia Maios, Meijiang Liao, Sorana Ciura, Xiao-Yan Wen, Victor Rafuse, Justin Ichida, Lorne Zinman, Jean-Pierre Julien, Edor Kabashi, Richard Robitaille, Lawrence Korngut, J. Alexander Parker & Pierre Drapeau. (2017) Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI Insight 2:22.
Crossref
Vijay Kumar, Asimul Islam, Md. Imtaiyaz Hassan & Faizan Ahmad. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. European Journal of Medicinal Chemistry 121, pages 903-917.
Crossref
Takehisa Isobe, Norie Tooi, Norio Nakatsuji & Kazuhiro Aiba. (2015) Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses. Stem Cell Research 15:3, pages 459-468.
Crossref
Allison S. Limpert & Nicholas D.P. Cosford. (2014) Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease. Journal of Clinical Investigation 124:3, pages 964-967.
Crossref
Allison S Limpert, Margrith E Mattmann & Nicholas D P Cosford. (2013) Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS). Beilstein Journal of Organic Chemistry 9, pages 717-732.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.